Injective INJ
Current Price
$2.92 -2.71%
$0.1400 Daily Range (4.79%)
$2.87$3.01
$36.84M Daily Volume
517 BTC
Vol/MktCap: 12.62%
Market Performance
0.10% Relative BTC Volume
The total volume of Injective is $36.84M over the past 24 hours, compared to $35.94B total Bitcoin volume.
Hourly Moving Average
8 SMA $2.91 +0.27%
13 SMA $2.91 +0.51%
21 SMA $2.92 +0.09%
55 SMA $2.92 -0.16%
144 SMA $2.86 +1.97%
Price Performance
+0.44% 1 Hour Change
$2.92 from $2.91
+4.78% 7 Day Change
$0.1396 from $2.78
-1.36% 14 Day Change
-$0.0398 from $2.96
-1.47% 30 Day Change
-$0.0428 from $2.96
All Time High
March 14, 2024
$52.62 -94.46%
-$49.70 vs. now
24H Change
-7.34M USD -2.45%
-103 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
12.53M INJ
traded over past 24 hours
12.53% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $2.91, reflecting a 3.04% decrease over the past 24 hours. The price has fluctuated between a daily high of $3.01 and a low of $2.87, indicating a relatively tight daily range of 0.14%.
Trading volume stands at approximately 27.05 million, which corresponds to a volume-to-market cap ratio of 9.29%. This suggests moderate trading activity relative to market capitalization, with interest potentially waning given the recent price decline.
Analyzing the moving averages reveals mixed signals; the 8-period SMA shows a slight increase of 0.40%, while the 13-period and 21-period SMAs indicate minimal declines. The longer-term 144-period SMA is showing a positive trend, rising by 1.75%, suggesting potential support at around $2.86.
The 1-hour Relative Strength Index (RSI) is at 34, indicating that INJ may be oversold in the short term. Conversely, the 7-day RSI sits at 53, reflecting a more neutral stance, while the 14-day and 30-day price changes are negative, suggesting downward pressure over longer periods.
Despite the recent price drop, INJ has shown a price increase of 4.55% over the past week, demonstrating some short-term resilience. However, with a significant gap from its all-time high of $52.62, the current price trajectory indicates substantial selling pressure.
Given the current technical indicators, including the bearish short-term momentum and the mixed moving average signals, the outlook for INJ appears cautious. Therefore, I recommend a Hold rating, as investors may want to wait for clearer bullish signals or a confirmed reversal before making any new positions.
Trading volume stands at approximately 27.05 million, which corresponds to a volume-to-market cap ratio of 9.29%. This suggests moderate trading activity relative to market capitalization, with interest potentially waning given the recent price decline.
Analyzing the moving averages reveals mixed signals; the 8-period SMA shows a slight increase of 0.40%, while the 13-period and 21-period SMAs indicate minimal declines. The longer-term 144-period SMA is showing a positive trend, rising by 1.75%, suggesting potential support at around $2.86.
The 1-hour Relative Strength Index (RSI) is at 34, indicating that INJ may be oversold in the short term. Conversely, the 7-day RSI sits at 53, reflecting a more neutral stance, while the 14-day and 30-day price changes are negative, suggesting downward pressure over longer periods.
Despite the recent price drop, INJ has shown a price increase of 4.55% over the past week, demonstrating some short-term resilience. However, with a significant gap from its all-time high of $52.62, the current price trajectory indicates substantial selling pressure.
Given the current technical indicators, including the bearish short-term momentum and the mixed moving average signals, the outlook for INJ appears cautious. Therefore, I recommend a Hold rating, as investors may want to wait for clearer bullish signals or a confirmed reversal before making any new positions.
Updated 85 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

BitMEX Co-Founder Ben Delo Reveals $5.4M Donation to Farage’s Reform UK
Delo’s donation to Reform UK comes amid a growing debate around the role of crypto donations in UK political funding.

Morgan Stanley Bitcoin ETF Draws In $31M on First Trading Day
The new fund launched amid a second straight day of outflows for Bitcoin ETFs, undercutting competitors with a 0.14% expense ratio.

RAIN faces critical test as $294 mln unlock looms – Can $0.0075 hold?
RAIN’s bounce follows a sharp decline, yet rising supply and fading volume keep the outlook uncertain.

XRP Faces No Immediate Quantum Threat As Only 0.03% Supply Seen At Risk: Analyst
A developer testnet for the XRP Ledger went fully quantum-secure back in December 2025 — months before most people started paying attention to the threat.